| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,455 |
5,856 |
$396K |
| 80053 |
Comprehensive metabolic panel |
3,532 |
2,841 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,819 |
1,602 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,000 |
3,057 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
953 |
913 |
$15K |
| 80061 |
Lipid panel |
1,727 |
1,528 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
952 |
799 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,216 |
1,943 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
7,784 |
5,575 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,397 |
889 |
$9K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
134 |
109 |
$6K |
| 85027 |
|
1,140 |
899 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
312 |
248 |
$4K |
| 86780 |
|
547 |
433 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
627 |
493 |
$2K |
| 84439 |
|
321 |
296 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
465 |
267 |
$2K |
| 86803 |
|
291 |
232 |
$2K |
| 82607 |
|
155 |
135 |
$2K |
| 82728 |
|
165 |
153 |
$2K |
| 86762 |
|
244 |
187 |
$2K |
| 86787 |
|
245 |
189 |
$1K |
| 84466 |
|
135 |
125 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
33 |
32 |
$1K |
| 82746 |
|
100 |
86 |
$901.81 |
| 83540 |
|
189 |
176 |
$879.16 |
| 86850 |
|
256 |
194 |
$875.21 |
| 81001 |
|
622 |
501 |
$824.68 |
| 87340 |
|
188 |
141 |
$726.68 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
171 |
147 |
$633.42 |
| 84481 |
|
34 |
33 |
$562.49 |
| 82043 |
|
89 |
85 |
$460.06 |
| 82570 |
|
96 |
89 |
$425.09 |
| 86706 |
|
64 |
52 |
$361.71 |
| 82950 |
|
182 |
152 |
$357.75 |
| 87077 |
|
33 |
31 |
$337.39 |
| 86901 |
|
255 |
192 |
$330.66 |
| 86900 |
|
254 |
192 |
$327.06 |
| 86038 |
|
12 |
12 |
$169.62 |
| 87186 |
|
15 |
14 |
$136.27 |
| 87631 |
|
45 |
45 |
$108.00 |
| 83735 |
|
17 |
12 |
$91.25 |
| 86140 |
|
12 |
12 |
$61.33 |
| 0353U |
|
130 |
101 |
$42.11 |
| 85652 |
|
14 |
14 |
$38.51 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
881 |
401 |
$0.00 |